<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00631319</url>
  </required_header>
  <id_info>
    <org_study_id>NMT 1077-302</org_study_id>
    <nct_id>NCT00631319</nct_id>
  </id_info>
  <brief_title>A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic OA Pain</brief_title>
  <acronym>OA Pain</acronym>
  <official_title>A Phase III, Flexible Dose Titration Followed by a Randomized Double-Blind Study of Controlled Release OROS Hydromorphone HCL Compared to Placebo in Patients With Chronic OA Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mallinckrodt</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mallinckrodt</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy of OROS Hydromorphone in reducing moderate to severe chronic pain in
      patients with Osteoarthritis (OA) Pain
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change from baseline to week 12 (or last visit) of the average PI of the DB treatment based on weekly avrg. PI scores from the patient diary.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Actual">200</enrollment>
  <condition>Chronic Pain</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OROS HYDROMORPHONE</intervention_name>
    <description>QD opioid pain reliever for OA pain-patients.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary clinic diagnosis of OA pain of the hip or of the knee for at least 6 months

          -  Patients required daily opioid medication to treat their chronic OA pain

        Exclusion Criteria:

          -  Joint replacement of the hip or of the knee that is the primary source of OA Pain

          -  History drug or alcohol abuse

          -  Fibromyalgia

          -  Patients who plan to have joint replacement surgery within the next 6 months

          -  Patients who have major depression or anxiety

          -  Women who are pregnant or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2008</study_first_submitted>
  <study_first_submitted_qc>February 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2008</study_first_posted>
  <last_update_submitted>March 20, 2012</last_update_submitted>
  <last_update_submitted_qc>March 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OA</keyword>
  <keyword>Chronic Pain</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>OA Pain</keyword>
  <keyword>Osteoarthritis Pain</keyword>
  <keyword>Pain</keyword>
  <keyword>Hip Pain</keyword>
  <keyword>Knee Pain</keyword>
  <keyword>Joint Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 3, 2012</submitted>
    <returned>June 11, 2012</returned>
    <submitted>July 13, 2012</submitted>
    <returned>August 28, 2012</returned>
    <submitted>August 16, 2016</submitted>
    <returned>October 10, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

